Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors

Circulation Research

Volumn 105, Issue 9, 2009, Pages 852-859

  Lemarié, Catherine A ^a   Simeone, Stefania M C ^a   Nikonova, Anna ^a   Ebrahimian, Talin ^a   Deschênes, Marie Eve ^a   Coffman, Thomas M ^b   Paradis, Pierre ^a   Schiffrin, Ernesto L ^a  

^a MCGILL UNIVERSITY   (Canada)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aldosterone; At1r; At1ar; At1br; Intracellular signaling

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN 1B RECEPTOR; ANGIOTENSIN II; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MINERALOCORTICOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STRESS ACTIVATED PROTEIN KINASE; ALDOSTERONE RECEPTOR; ANGIOTENSIN 1 RECEPTOR; PROTEIN C FOS;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; GENOMICS; HORMONE ACTION; MOUSE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INDUCTION; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; C57BL MOUSE; CELL CULTURE; GENETICS; MALE; METABOLISM; MOUSE MUTANT; PHOSPHORYLATION; RNA INTERFERENCE; TIME;

ALDOSTERONE; ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTOR CROSS-TALK; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ALDOSTERONE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 70350743265     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.109.196576     Document Type: Article

References (31)

1. Callera GE, Montezano AC, Yogi A, Tostes RC, He Y, Schiffrin EL, Touyz RM. c-Src-dependent nongenomic signaling responses to aldosterone are increased in vascular myocytes from, spontaneously hypertensive rats. Hypertension. 2005;46:1032-1038.
2. Mazak I, Fiebeler A, Muller DN, Park JK, Shagdarsuren. E, Lindschau C, Dechend R, Viedt C, Pilz B, Haller H, Luft FC. Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells. Circulation. 2004;109:2792-2800. (Pubitemid 38737927)
3. Min LJ, Mogi M, Li JM, Iwanami J, Iwai. M, Horiuchi M. Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells. Circ Res. 2005;97:434-442. (Pubitemid 41298173)
4. Schiffrin EL, Franks DJ, Gutkowska J. Effect of aldosterone on vascular angiotensin II receptors in the rat. Can J Physiol Pharmacol. 1985;63: 1522-1527.
5. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709-717.
6. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309-1321.
7. Schiffrin EL, Thome FS, Genest J. Vascular angiotensin II receptors in renal and DOCA-salt hypertensive rats. Hypertension. 1983;5:V16-V21.
8. Schiffrin EL, Gutkowska J, Genest J. Effect of angiotensin II and deoxycorticosterone infusion on vascular angiotensin II receptors in rats. Am J Physiol. 1984; 246:H608-H614.
9. Xiao F, Puddefoot JR, Barker S, Vinson GP. Mechanism for aldosterone potentiation of angiotensin. II-sdmulated rat arterial smooth muscle cell proliferation. Hypertension. 2004;44:340-345.
10. Jaffe IZ, Mendelsohn ME. Angiotensin. II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Circ Res. 2005;96:643-650.
11. Min LJ, Mogi M, Iwanami J, Li JM, Sakata A, Fujita T, Tsukuda K, Iwai M, Horiuchi M. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence. Cardiovasc Res. 2007;76: 506-516.
12. Touyz RM, Tolloczko B, Schiffrin EL. Mesenteric vascular smooth muscle cells from spontaneously hypertensive rats display increased calcium responses to angiotensin II but not to endothelin-1. J Hypertens. 1994;12:663-673.
13. TouyzRM,HeG,DengLY,SchiffrinEL. RoleofextracellularsignalregulatedkinasesinangiotensinII- stimulatedcontractionofsmoothmusclecellsfrom,humanresistancearteries. Circulation.1999;99:392-399.(Pubitemid29051265)
14. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, Coffman TM. Regulation of blood, pressure by the type IA angiotensin II receptor gene. Proc Natl Acad Sci U S A. 1995;92:3521-3525.
15. Rajotte D, Sadowski HB, Haman A, Gopalbhai K, Meloche S, Liu L, Krystal G, Hoang T. Contribution of both STAT and SRF/TCF to c-fos promoter activation by granulocyte-macrophage colony-stimulating factor. Blood. 1996;88:2906-2916.
16. HaradaE,YoshimuraM,YasueH,NakagawaO,NakagawaM,HaradaM,MizunoY,NakayamaM, ShimasakiY,ItoT,NakamuraS,KuwaharaK,SaitoY,NakaoK,OgawaH. Aldosteroneinducesangiotensinconverting- enzymegeneexpressioninculturedneonatalratcardiocytes.Circulation.2001;104: 137-139.(Pubitemid32655827)
17. Fiebeler A, Schmidt F, Muller DN, Park JK, Dechend R, Bieringer M, Shagdarsuren E, Breu V, Haller H, Luft FC. Mineralocorticoid receptor affects AP-I and nuclear factor-kappab activation in angiotensin II-induced cardiac injury. Hypertension. 2001;37:787-793.
18. Virdis A, Neves MF, Amiri F, Viel E, Touyz RM, Schiffrin EL. Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension. 2002;40:504-510.
19. Onozato ML, Tojo A, Kobayashi N, Goto A, Matsuoka H, Fujita T. Dual, blockade of aldosterone and angiotensin 11 additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney. Nephrol Dial Transplant. 2007;22:1314-1322. (Pubitemid 47072218)
20. Schiffrin EL. New twist to the role of the renin-angiotensin system, in heart failure: aldosterone upregulates renin-angiotensin system components in the brain. Hypertension. 2008;51:622-623.
21. Montezano AC, Callera GE, Yogi. A, He Y, Tostes RC, He G, Schiffrin EL, Touyz RM. Aldosterone and angiotensin II synergistically stimulate migration, in vascular smooth muscle cells through c-Src-regulated redoxsensitive RhoA pathways. Arterioscler Thromb Vase Biol. 2008;28: 1511-1518.
22. Rousseau MF, Gume O, Duprez D, Van Mieghem. W, Robert A, Ahn S, Galanti L, Ketelslegers JM. Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy. J Am Coll Cardiol. 2002;40:1596-1601.
23. Silvestre JS, Robert V, Heymes C, Aupetit-Faisant B, Mouas C, Moalic JM, Swynghedauw B, Delcayre C. Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation. J Biol Chem. 1998;273:4883-4891. (Pubitemid 28108638)
24. Weber KT. Aldosterone in congestive heart failure. N Engl J Med. 2001;345:1689-1697.
25. Wehling M, Neylon CB, Fullerton M, Bobik A, Funder JW. Nongenomic effects of aldosterone on intracellular Ca2+ in vascular smooth muscle cells. Circ Res. 1995;76:973-979.
26. Li XC, Zhuo JL. In vivo regulation of AT1a receptor-mediated intracellular uptake of [125I]Val5-ANG II in the kidneys and adrenals of ATIa receptor-deficient mice. Am J Physiol Renal Physiol, 2008;294: F293-F302.
27. Chen X, Li W, Yoshida H, Tsuchida S, Nishimura H, Takemoto F, Okubo S, Fogo A, Matsusaka T, Ichikawa I. Targeting deletion of angiotensin type IB receptor gene in the mouse. Am J Physiol. 1997; 272:F299-F304.
28. Wildling L, Hinterdorfer P, Kusche-Vihrog K, Treffner Y, Oberleithner H. Aldosterone receptor sites on plasma membrane of human vascular endothelium detected by a mechanical nanosensor. Pflugers Arch. 2009; 458:223-230.
29. Yamada M, Kushibiki M, Osanai T, Tomita H, Okumura K. Vasoconstrictor effect of aldosterone via angiotensin. II type 1 (AT1) receptor: possible role of ATI receptor dimerization. Cardiovasc Res. 2008;79: 169-178.
30. Zou Y, Akazawa H, Qin Y, Sano M, Takano H, Minamino T, Makita N, Iwanaga K, Zhu W, Kudoh S, Toko H, Tamura K, Kihara M, Nagai T, Fukamizu. A, Umemura S, Iiri T, Fujita T, Komuro I. Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat Cell Biol. 2004;6:499-506.
31. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological, and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev. 2000;52:639-672.